A. Kotecha

发表

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

D. Schroeder, P. Kamath, K. Swanson, 2018, Mayo Clinic proceedings.

Saddle vs Nonsaddle Pulmonary Embolism: Clinical Presentation, Hemodynamics, Management, and Outcomes

V. Iyer, R. Kashyap, D. Apala, 2017, Mayo Clinic proceedings.

Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia

P. Kamath, C. Wood, K. Swanson, 2018, Advances in hematology.

Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab

A. Deol, A. Kotecha, P. Chandrasekar, 2016, Annals of Hematology.

Development and performance of a novel vasopressor-driven mortality prediction model in septic shock

Dennis H. Murphree, E. Barreto, A. Khanna, 2018, Annals of Intensive Care.

Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability

V. Iyer, D. Apala, A. Kotecha, 2017, Respiratory medicine case reports.

Cardiorenal syndrome in sepsis: A narrative review

K. Kashani, S. Vallabhajosyula, A. Kotecha, 2018, Journal of critical care.

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Mohammad Sohel Rahman, Henrik Nielsen, M. Shankar-Hari, 2021, BMC Infectious Diseases.

Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy

A. Kotecha, J. Pimentel, G. Krishnamoorthy, 2019, BMJ Case Reports.